CONCERT PHARMACEUTICALS, INC. 4
4 · CONCERT PHARMACEUTICALS, INC. · Filed Feb 19, 2014
Insider Transaction Report
Form 4
Daws D. Ryan
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2014-02-19+123,893→ 123,893 totalExercise: $14.09Exp: 2024-02-19→ Common Stock (123,893 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the original 123,893 shares on January 20, 2015 and vests as to an additonal 6.25% of the original shares at the end of each successive three-month period through and including January 20, 2019.